Literature DB >> 8847395

Frontal lobe lesions, diffuse damage, and neuropsychological functioning in traumatic brain-injured patients.

C V Anderson1, E D Bigler, D D Blatter.   

Abstract

This study quantified lesion volume in relation to damage location and executive functioning in traumatic brain-injured (TBI) patients. Magnetic resonance (MR) scans of 68 TBI patients were analyzed by taking volumetric measures of lesion sites. Patients were grouped according to the presence/absence of frontal lobe lesions. Measures of frontal lesion volume were studied as predictors for outcome on designated tests of executive functioning (Halstead Category Test and Wisconsin Card Sorting Test). Results showed no significant differences in level of deficit between groups. In addition, no significant differences were found between groups on other tests of neuropsychological functioning (Trail Making Test, Parts A and B, and Wechsler Adult Intelligence Scale-Revised). These results suggest that tests that are traditionally used to detect "frontal lobe" damage may not be adequate for distinguishing specific frontal lobe dysfunction, and do not add anything unique about frontal lobe integrity and neuropsychological functioning in TBI patients.

Entities:  

Mesh:

Year:  1995        PMID: 8847395     DOI: 10.1080/01688639508402438

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  22 in total

1.  Operating characteristics of executive functioning tests following traumatic brain injury.

Authors:  Jason A Demery; Michael J Larson; Neha K Dixit; Russell M Bauer; William M Perlstein
Journal:  Clin Neuropsychol       Date:  2010-11       Impact factor: 3.535

2.  The development of a trial making test in young children: the TRAILS-P.

Authors:  Kimberly Andrews Espy; Mary F Cwik
Journal:  Clin Neuropsychol       Date:  2004-08       Impact factor: 3.535

3.  Aging and inhibitory errors on a motor shift of set task.

Authors:  Lauren M Potter; Madeleine A Grealy
Journal:  Exp Brain Res       Date:  2005-11-24       Impact factor: 1.972

4.  The Relationship Between Gray Matter Morphometry and Neuropsychological Performance in a Large Sample of Cognitively Healthy Adults.

Authors:  Lisa M Newman; Mehul A Trivedi; Barbara B Bendlin; Michele L Ries; Sterling C Johnson
Journal:  Brain Imaging Behav       Date:  2007       Impact factor: 3.978

Review 5.  The Halstead Category Test: a fifty year perspective.

Authors:  J P Choca; L Laatsch; L Wetzel; A Agresti
Journal:  Neuropsychol Rev       Date:  1997-06       Impact factor: 7.444

6.  Development of a modified naturalistic action test for korean patients with impaired cognition.

Authors:  Mi Ae Jung; Hyun Jung Kim; Youn Joo Kang; Yon Joon Kim
Journal:  Ann Rehabil Med       Date:  2013-02-28

Review 7.  A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury.

Authors:  M E Shenton; H M Hamoda; J S Schneiderman; S Bouix; O Pasternak; Y Rathi; M-A Vu; M P Purohit; K Helmer; I Koerte; A P Lin; C-F Westin; R Kikinis; M Kubicki; R A Stern; R Zafonte
Journal:  Brain Imaging Behav       Date:  2012-06       Impact factor: 3.978

8.  Validity of the Verbal Concept Attainment Test in multiple sclerosis.

Authors:  Ryan Mulligan; Michael R Basso; Lily Lau; Bradley Reynolds; Douglas M Whiteside; Dennis Combs; Robert A Bornstein
Journal:  J Clin Exp Neuropsychol       Date:  2019-01-14       Impact factor: 2.475

9.  Acute cognitive deficits after traumatic brain injury predict Alzheimer's disease-like degradation of the human default mode network.

Authors:  Andrei Irimia; Alexander S Maher; Nikhil N Chaudhari; Nahian F Chowdhury; Elliot B Jacobs
Journal:  Geroscience       Date:  2020-08-02       Impact factor: 7.713

10.  Longitudinal volumetric changes following traumatic brain injury: a tensor-based morphometry study.

Authors:  Kimberly D M Farbota; Aparna Sodhi; Barbara B Bendlin; Donald G McLaren; Guofan Xu; Howard A Rowley; Sterling C Johnson
Journal:  J Int Neuropsychol Soc       Date:  2012-08-13       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.